Robert Horlick - San Diego CA, US David King - Encinitas CA, US Peter Bowers - San Diego CA, US Jennifer Dalton - Cardiff CA, US Betty Wu - San Diego CA, US Traci Roberts - San Diego CA, US Xue Zhang - San Diego CA, US Laurence Altobell, III - San Diego CA, US
The disclosure relates to an isolated IL-17-binding agent which comprises an immunoglobulin heavy chain polypeptide comprising SEQ ID NO: 1 and optionally an immunoglobulin light chain polypeptide comprising SEQ ID NO: 23, except that one or more specific of residues of SEQ ID NO: 1 and SEQ ID NO: 23 are replaced with a different residue. The disclosure also provides vectors, compositions, and methods of using the IL-17-binding agent to treat an IL-17-mediated disease.
Human Immunodeficiency Virus Neutralizing Antibodies
- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Pacifica CA, US Nathan D. Thomsen - Castro Valley CA, US Xue Zhang - San Diego CA, US
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Antibodies That Target Hiv Gp120 And Methods Of Use
- Foster City CA, US Brian A. Carr - Foster City CA, US Magdeleine S. Hung - Mountain View CA, US Manu Kanwar - San Marcos CA, US Craig S. Pace - Belmont CA, US Doug Rehder - Bonsall CA, US Matthew Robert Schenauer - Dana Point CA, US Loredana Serafini - Orinda CA, US Heather Theresa Stephenson - San Jose CA, US Nathan D. Thomsen - Castro Valley CA, US Helen Yu - Mountain View CA, US Xue Zhang - San Diego CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07K 16/10 A61P 31/18
Abstract:
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Human Immunodeficiency Virus Neutralizing Antibodies
- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Belmont CA, US Nathan D. Thomsen - Castro Valley CA, US Xue Zhang - San Diego CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Human Immunodeficiency Virus Neutralizing Antibodies
- Foster City CA, US Brian A. Carr - Foster City CA, US John Corbin - Oakland CA, US Craig S. Pace - Belmont CA, US Nathan D. Thomson - Castro Valley CA, US Xue Zhang - San Diego CA, US
International Classification:
C07K 16/10
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
License Records
Xue Sheng Zhang
License #:
78949 - Expired
Category:
Engineers
Issued Date:
Mar 26, 2015
Effective Date:
Mar 14, 2017
Expiration Date:
Feb 28, 2017
Type:
Professional Engineer
Xue Yan Zhang
Address:
Philadelphia, PA 19148
License #:
RN687430 - Active
Category:
Nursing
Type:
Registered Nurse
Name / Title
Company / Classification
Phones & Addresses
Xue Juan Zhang Manager
A2A Resources LLC
5 Wilde Ave, Oakview, PA 19026 2011 S Rdg Pt Way, Boise, ID 83712
Abt Associates
Finance Controller
Ntt Data Services Oct 2012 - Feb 2018
Financial Analysis Senior Advisor
Mitre Aug 2010 - Jun 2012
Senior Financial Analyst
Dell Oct 2006 - Jul 2010
Financial Analyst
General Dynamics Information Technology Jan 2006 - Oct 2006
Budget and Financial Analyst I
Education:
Pennsylvania State University May 2005
Bachelors, Bachelor of Science
Penn State University 2001 - 2005
Bachelors, Finance
Skills:
Financial Analysis Financial Modeling Analysis Forecasting Financial Reporting Budgets Pricing Data Analysis Government Contracting Business Analysis Microsoft Excel Process Improvement Team Leadership Program Management Project Management Finance Analytical Skills Budgeting
La Salle University 2012 - 2016
Bachelors, Nursing
Skills:
Microsoft Excel Powerpoint Microsoft Word Public Speaking Microsoft Office Research Customer Service Teaching Outlook Risk Management Teamwork Training Nonprofits Staff Development Credit Banking Budgets Financial Analysis Strategic Planning Data Analysis Coaching Fundraising Community Outreach Event Planning Volunteer Management Social Media Higher Education Editing Grant Writing Program Development Public Relations Healthcare Critical Thinking Time Management Customer Satisfaction Deposits Sales Cash Handling Experience Leadership Cpr Certified Social Networking Nursing Nursing Care Nursing Documentation Nursing Process Patient Safety Hospitals Management
Interests:
Social Services Children Civil Rights and Social Action Education Environment Poverty Alleviation Science and Technology Disaster and Humanitarian Relief Human Rights Animal Welfare Arts and Culture Health
Gilead Sciences
Senior Research Scientist
Ambrx Mar 2014 - Jun 2014
Scientist
Gilead Sciences Mar 2014 - Jun 2014
Research Scientist at Gilead Sciences
Anaptysbio May 2010 - Aug 2013
Scientist Ii
Gnf Apr 2007 - May 2010
Institute Fellow
Education:
Uc Berkeley Extension 2017 - 2019
Baylor College of Medicine 1997 - 2003
Doctorates, Doctor of Philosophy, Biochemistry
University of Houston
Nankai University
Bachelors, Bachelor of Science, Biochemistry
Skills:
Assay Development Cell Biology Drug Discovery Cell Biochemistry Elisa Cell Culture High Throughput Screening Antibodies Molecular Biology Protein Chemistry Flow Cytometry Tissue Culture Mammalian Cell Culture Purification In Vivo In Vitro Animal Models Monoclonal Antibodies Protein Expression Protein Purification Western Blotting Pcr Molecular Cloning Sequencing Confocal Microscopy Immunology Fluorescence Sds Page Biomarker Discovery
"We wanted to see whether this problem-solving therapy in particular could modulate the cognitive control circuit," said Xue Zhang, Ph.D., a postdoctoral scholar in psychiatry who is the lead author of the study.